• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Cuba grants emergency approval to second homegrown vaccine

firstwordpharmaAugust 23, 2021

Tag: Cuba , COVID-19 , Vaccine

Cuba's Center for State Control of Medicines, Equipment and Medical Devices granted emergency approval to the Soberana 2 vaccine for the prevention of COVID-19, as reported in National Post.

Cuba grants emergency approval to second homegrown vaccine

Approval means the vaccine, which is comprised of two initial shots and a booster, can be included in the national immunisation programme.

The Soberana 2 vaccine is said to have an efficacy rate of 91.2% and has already been used in Cuba to vaccinate some health workers and ordinary citizens in areas with high rates of transmission.


Previous:Vividion Therapeutics officially withdraws $100 million IPO following acquisition by Bayer

Next:Spotting the Signs of Deadly Melanoma Skin Cancers

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Cuba grants emergency approval to second homegrown vaccine | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Heating Incubator(natural convection)

Heating Incubator(natural convection)
SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)

SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)
Hualan's Influenza Vaccine

Hualan's Influenza Vaccine
*trivalent flu vaccine

*trivalent flu vaccine
Influenza Vaccine in Syringe Form

Influenza Vaccine in Syringe Form
Recombinant Hepatitis B Vaccine

Recombinant Hepatitis B Vaccine
Hualan bio Inactivated Influenza Vaccine (Split virion)with stable quality

Hualan bio Inactivated Influenza Vaccine (Split virion)with stable quality
Hualan Biological Recombinant Hepatitis B Vaccine (Hansenula polymorpha)with Excellent bacteria stra

Hualan Biological Recombinant Hepatitis B Vaccine (Hansenula polymorpha)with Excellent bacteria stra
CO2 Cell Incubator WJ-3

CO2 Cell Incubator WJ-3
Heating lid dry bath incubator

Heating lid dry bath incubator

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service